6KUMAR S, BOULTOM A J M, BECK-NIELSON H, et al.Troglitazone an insuline action enhancer, improves metabolic in NIDDM patients[J]. Diabetologia, 1996,39 (4): 701.
7JEPPESEN J, ZHOU M Y, CHEN Y D, et al. Effect of metform in on postprandial lipemia in patients with fairly to poorly controlled NIDDM[J]. Diabetes Care, 1994, 17 (10):1093-1099.
6Pickup JC, Crook MA. Is type 2 diabetes mellitus a disease of innate immune system? [J]. Diabetologia, 1998, 41(10) :1241- 1248.
7Ariel RJ. Significance of uric acid for the heart and vessels [J]. Eur Heart J,2006,27(15) :1886.
8Culleton BF, Larson MG,Kannel WB, et al. Serum uric acid and risk for cardiovascular disease and death:the Framingham Heart Study [J]. Ann Intern Med,1999,131(1):7-13.
9The Expert Committee on the Diagnosis and the Classification of the Diabetes Mellitus. Follow-up report of the expert committee on the diagnosis and classification of diabetes mellitus [J].Diabetes care,2003,26:3160- 3167.
